Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Leukemia (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lymphoma (Phase 1/Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Tumor Suppressor Protein p53 (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue